On Feb 16, we issued an updated research report on Illumina, Inc. ILMN. The company’s market opportunities continue to expand owing to accelerated demand from clinical and translational customers.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Phoenix, AZ, March 28, 2007—The NIH Neuroscience Microarray Consortium today announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services.

Wall Street analysts forecast that Illumina (ILMN) will report quarterly earnings of $0.13 per share in its upcoming release, pointing to a year-over-year decline of 61.8%. It is anticipated that ...

When scientists finished mapping the human genome, they thought their work was done. However, they have since found out that there is such a thing as too much information. There are only a little more ...